MLH1 and ovarian carcinoma: Consistent with our results using the paired human ovarian cancer cells lines, these results suggest that loss of MLH1 does not diminish the mutagenic potential of triplex-directed psoralen ICLs in human cells, therefore MLH1 function is not required for the mutagenic processing of psoralen ICLs in HeLa cells.